Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP-FLUMAZENIL 0.1 MG — DIN 02431750

FLUMAZENIL : 0.1 MG · JAMP PHARMA CORPORATION · SOLUTION · wholesale supply in Canada

Health Canada status: APPROVED

What is JAMP-FLUMAZENIL?

JAMP-FLUMAZENIL 0.1 MG contains FLUMAZENIL : 0.1 MG. It is listed in the Health Canada Drug Product Database under DIN 02431750, held by JAMP PHARMA CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 31-Oct-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.

How much does Flumazenil cost around the world?

Flumazenil is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Brazil publishes a preco fabrica (ex-factory ceiling); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Italyex-factory (classe H)810EUR███.██
Brazilpreco fabrica (ex-factory ceiling)48BRL███.██
Greeceproducer price (ex-factory)44EUR███.██
Norwaymax AUP (pharmacy retail)44NOK███.██
United Statesacquisition14USD███.██
Saudi Arabiapublic33SAR███.██
South Africasingle exit price33ZAR███.██
United Kingdomhospital22GBP███.██
United Arab Emiratespublic11AED███.██
Bahrainretail (max)11BHD███.██
Hungaryproducer price (ex-factory)11HUF███.██
MoroccoPPV (public price)11MAD███.██
Romaniamax producer price11RON███.██
Slovakiacategorised final price11EUR███.██

44 pack listings across 35 brand entries and 12 price bases, refreshed 07 Sep 2026. Ranges span every Flumazenil pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Flumazenil in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

5 holders have a Canadian DIN containing Flumazenil, across 6 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
SANDOZ CANADA INCORPORATED21FLUMAZENIL INJECTION, FLUMAZENIL INJECTION SDZSourceable in Canada
FRESENIUS KABI CANADA LTD11FLUMAZENIL INJECTION, USPSourceable in Canada
HOFFMANN-LA ROCHE LIMITED10ANEXATE INJ 0.1MG/MLNo marketed DIN
JAMP PHARMA CORPORATION10JAMP-FLUMAZENILNo marketed DIN
MYLAN PHARMACEUTICALS ULC10FLUMAZENIL INJECTION, USPNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label0.1 MG
Dosage formSOLUTION
RouteINTRAVENOUS

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceFlumazenil
ATC codeV03AB25
AHFS class91:32.04
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02431750
DIN (unpadded, as printed on some documents)2431750
Brand nameJAMP-FLUMAZENIL
Generic / active ingredientFLUMAZENIL : 0.1 MG
Market authorization holderJAMP PHARMA CORPORATION
Health Canada scheduleEthical
ATC codeV03AB25
ATC anatomical main groupV — Various
ATC therapeutic subgroupV03AB
Current statusAPPROVED
Status date31-Oct-2014
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

2 of 6 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
FLUMAZENIL INJECTION0.1 MGSOLUTIONSANDOZ CANADA INCORPORATEDMARKETED02249561
FLUMAZENIL INJECTION, USP0.1 MGSOLUTIONFRESENIUS KABI CANADA LTDMARKETED02266342
ANEXATE INJ 0.1MG/ML0.1 MGSOLUTIONHOFFMANN-LA ROCHE LIMITEDCANCELLED POST MARKET00874019
FLUMAZENIL INJECTION SDZ0.1 MGSOLUTIONSANDOZ CANADA INCORPORATEDCANCELLED PRE MARKET02388995
FLUMAZENIL INJECTION, USP0.1 MGSOLUTIONMYLAN PHARMACEUTICALS ULCCANCELLED PRE MARKET02430169

2 · Same class — other molecules in ATC V03AB

MoleculeCanadian brandsDINsMarketedSourceable
NaloxoneINJECTABLE NALOXONE HYDROCHLORIDE · KLOXXADO · NALOXONE HCL INJECTION - 0.4MG/ML USP · NALOXONE HCL INJECTION - 1MG/ML USP · +11 more2612Yes
SugammadexBRIDION · PMS-SUGAMMADEX · SUGAMMADEX · SUGAMMADEX INJECTION · +1 more144Yes
ThiosulphateSEACALPHYX · SODIUM THIOSULFATE INJ 25% USP · SODIUM THIOSULFATE INJECTION USP43Yes
Methylthioninium ChlorideMETHYLENE BLEU LIQ 2% · METHYLENE BLUE INJ 1% · METHYLENE BLUE INJ 1% USP · METHYLENE BLUE INJ 10MG/ML USP · +3 more112Yes
FlumazenilANEXATE INJ 0.1MG/ML · FLUMAZENIL INJECTION · FLUMAZENIL INJECTION SDZ · FLUMAZENIL INJECTION, USP · +1 more62Yes
ProtaminePROTAMINE SULFATE INJ 10MG/ML USP · PROTAMINE SULFATE INJECTION USP · PROTAMINE SULFATE INJECTION, USP42Yes
FomepizoleANTIZOL · FOMEPIZOLE FOR INJECTION22Yes
HydroxocobalaminCYANOKIT21Yes
Digitalis AntitoxinDIGIBIND · DIGIFAB21Yes
IdarucizimabPRAXBIND11Yes

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC V03A

ATC subgroupMoleculesDINsMarketed
V03ACDeferasirox · Deferiprone · Deferoxamine5744
V03ANCarbon Dioxide · Combination · Helium · Medical Air · Medical Gases · +2 more11243
V03AECalcium Acetate · Drugs For Treatment Of Hyperkalemia And Hyperphosphatemia · Lanthanum Carbonate · Patiromer Calcium · Polystyrene Sulphonate · +3 more4019
V03AFAmifostine · Calcium Folinate · Dexrazoxane · Mesna · Palifermin · +1 more3416
V03AHDiazoxide21
V03AXCobicistat · Difelikefalin · Other Therapeutic Products81
V03AZEthanol10

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is JAMP-FLUMAZENIL called?

The same molecule, Flumazenil, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
FLUMAZENILLatinBrazil
EXITINELatinSaudi Arabia
FLOMOZILLatinBahrain
Flumazenil Aurora MedicalLatinNorway
Flumazenil Fresenius KabiLatinNorway
Flumazenil HamelnLatinNorway
Flumazenil OrifarmLatinNorway
Flumazenil PSILatinSaudi Arabia
FLUMAZILLatinBrazil
LANEXATLatinBrazil
LENAZENLatinBrazil

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.

Ask about availability of JAMP-FLUMAZENIL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02431750. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.